Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Prof. Ma Jun Highlights ASH Conference, Showcasing Chinese Influence on Global Stage

    Local time on December 9th, the eagerly awaited 65th American Society of Hematology (ASH) Annual Meeting officially kicked off in San Diego, USA. The Oncology Insight reporting team delved into the forefront, witnessing the impressive presence of “The Voice of China” on the international stage. ASH is one of the largest and most comprehensive international…

    2024.01.05
  • APASL 2023 | Prof. Jia Jidong: Latest Advances in Primary Biliary Cholangitis

    Editor’s Note: Primary Biliary Cholangitis (PBC) is a chronic cholestatic liver disease mediated by autoimmunity, with its pathogenesis not yet fully understood. Traditionally, PBC was thought to predominantly affect Western…

    2024.01.04
  • 2023 ASH丨Professor Jiang Qian: Discussing Drug Resistance in Chronic Myeloid Leukemia (CML) Treatment and the Value of Novel TKIs

    The 65th Annual Meeting of the American Society of Hematology (ASH) recently concluded, with significant contributions in the field of Chronic Myeloid Leukemia (CML) treatment. Professor Jiang Qian and her team from Peking University People’s Hospital presented multiple studies, with abstracts 867 and 869 selected for oral presentations. These reports highlighted the potential of TGRX-678…

    2024.01.04
  • APASL 2023|Professor Duan Zhongping: HDV Infection in Chronic HBV Infected Patients at Different Disease Stages

    Editor’s Note: Viral hepatitis has imposed a significant disease burden globally. While China’s efforts in controlling viral hepatitis have shown initial success, the large number of chronic viral hepatitis patients…

    2024.01.04
  • APASL 2023 | Prof. Hu Jinhua: Liver Cell Regeneration and Its Application in Liver Failure Treatment

    Editor’s Note: At the 32nd Asia-Pacific Association for the Study of the Liver (APASL) annual conference, Professor Hu Jin-Hua from the Department of Hepatology at the Fifth Medical Center of…

    2024.01.04
  • Professor Xiaojun Huang Awarded International Collaboration Award by IACH

    Renowned hematologist Professor Xiaojun Huang has been honored with the International Collaboration Award by the International Academy for Clinical Hematology (IACH). Prof. Huang, a pioneer in the successful implementation of haploidentical transplantation, has significantly contributed to the field of clinical hematology and played a crucial role in promoting global collaboration. The award ceremony took place…

    2024.01.04
  • APASL 2023 | Prof. Ji Dong: Clinical Characteristics of Elderly Drug-Induced Liver Injury Combined with Autoimmune Phenomena

    Editor’s Note: In recent years, with the increase in health awareness, the incidence of drug-induced liver injury (DILI) has been rising. Immune responses can trigger inflammation and necrosis, leading to…

    2024.01.03
  • APASL 2023 | Prof. Li Hai: Latest Advances in Prognostic Research for Acute-on-Chronic Liver Failure

    Editor’s Note: Acute-on-Chronic Liver Failure (ACLF) is a clinical syndrome characterized by a rapid and severe deterioration in a short term, often accompanied by multi-organ failure and a high mortality…

    2024.01.03
«previous next»
Recent Posts
  • Published in JCO! Professor Lin Shen’s Team Reports the World’s First Published Positive Phase III Data for a Dual PD-L1/TGF-β-Targeting Agent, Reshaping First-Line Treatment for HER2-Negative Advanced Gastric Cancer
  • “Zhong” Voice, “Hui” Insights Series, Episode 33: Exploring IL-1β Blockade Combined with Concurrent Chemoradiotherapy and Maintenance Immunotherapy in Unresectable Stage III NSCLC — An Interpretation of the CHORUS Study
  • Professor Hua Huang on Selecting Beneficiaries of Perioperative Gastric Cancer Therapy, Reassessing the Value of Conversion Surgery for Peritoneal Metastases, and the Path from Surgeon to “Clinical Scientist” for Young Surgeons | CGCC 2026
  • New Evidence, New Possibilities | Professor Lijun Tian: First Real-World Case of Andaritini Demonstrates Simultaneous Intracranial and Extracranial Responses Within Just Three Months in EGFR-Mutant Advanced NSCLC with Acquired Resistance
  • SIBCS 2026 | Professors Lu Gan, Huihui Li, and Jian Huang: From Mechanisms to Clinical Practice—ADC Sequencing Strategies and the Distinctive Value of Bodutuzumab in HER2-Positive Advanced Breast
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top